News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CytoDyn Engages the Trout Group for Investor Relations Services


4/15/2012 9:44:51 PM

LUTZ, Fla., April 13, 2012 (GLOBE NEWSWIRE) -- CytoDyn Inc. (the "Company") (OTCQB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, and other antibody applications, announced today that it has engaged The Trout Group LLC, a leading investor relations and strategic advisory firm.

Read at GlobeNewswire


comments powered by Disqus
CytoDyn
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES